Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). YS Biopharma Co's share price for the quarter that ended in Sep. 2023 was $0.8. YS Biopharma Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 93.06 Mil. Therefore, YS Biopharma Co's market cap for the quarter that ended in Sep. 2023 was $74.45 Mil.
YS Biopharma Co's quarterly market cap
increased
from Sep. 2022 ($0.00 Mil) to Mar. 2023 ($148.89 Mil) but then
declined
from Mar. 2023 ($148.89 Mil) to Sep. 2023 ($74.45 Mil).
YS Biopharma Co's annual market cap
stayed the same
from Mar. 2021 ($0.00 Mil) to Mar. 2022 ($0.00 Mil) but then
increased
from Mar. 2022 ($0.00 Mil) to Mar. 2023 ($148.89 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. YS Biopharma Co's Enterprise Value for Today is $226.77 Mil.
YS Biopharma Co Market Cap Historical Data
The historical data trend for YS Biopharma Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of YS Biopharma Co's Market Cap
For the Biotechnology subindustry, YS Biopharma Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
YS Biopharma Co's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, YS Biopharma Co's Market Cap distribution charts can be found below:
* The bar in red indicates where YS Biopharma Co's Market Cap falls into.
YS Biopharma Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
YS Biopharma Co's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YS Biopharma Co (NAS:YS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
YS Biopharma Co Market Cap Related Terms
Thank you for viewing the detailed overview of YS Biopharma Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
YS Biopharma Co (YS Biopharma Co) Business Description
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
YS has been successfully added to your